Roier, Sandro
Mangala Prasad, Vidya
McNeal, Monica M.
Lee, Kelly K.
Petsch, Benjamin http://orcid.org/0000-0001-7431-0683
Rauch, Susanne http://orcid.org/0009-0008-4587-5384
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-020846, INV-020846, OPP-1126258, INV-020846, OPP-1126258, INV-020846)
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Article History
Received: 31 March 2023
Accepted: 5 December 2023
First Online: 22 December 2023
Competing interests
: S.Ro., B.P., and S.Ra. are employees of CureVac SE, Tübingen, Germany, a publicly listed company developing mRNA-based vaccines and immunotherapeutics, and are inventors on several patents on mRNA vaccination and use thereof. S.Ro. and B.P. hold shares in the company. The other authors declare no competing interests.